Suppr超能文献

在猪心肌中,U - 89232诱导的梗死面积缩小对格列本脲敏感:证明U - 89232是ATP敏感性钾通道的心脏选择性开放剂。

In swine myocardium, the infarct size reduction induced by U-89232 is glibenclamide sensitive: evidence that U-89232 is a cardioselective opener of ATP-sensitive potassium channels.

作者信息

Rohmann S, Fuchs C, Schelling P

机构信息

Department of Preclinical Cardiovascular Research, Merck KGaA, Darmstadt, Germany.

出版信息

J Cardiovasc Pharmacol. 1997 Jan;29(1):69-74. doi: 10.1097/00005344-199701000-00011.

Abstract

We determined whether U-89232, a derivative of the ATP-sensitive potassium (KATP) channel opener cromakalim, is cardioselective and whether its action on the myocardium is still sensitive to glibenclamide. Experiments were performed in open-chest pigs subjected to a 60-min occlusion of the left anterior descending coronary artery (LADCA) and to 2 h of reperfusion. Four groups of animals were studied (n = 6 each). Animals received either U-89232, 3 mg/kg i.v. over a 15-min period (U), or glibenclamide, a selective KATP channel blocker, 1 mg/kg i.v. over a 15-min period (GLI) before the LADCA occlusion. In the GLI + U group, first glibenclamide (1 mg/kg/15 min) and then U-89232 (3 mg/kg/15 min) were infused before the 60 min of ischemia. Saline-treated animals served as controls (CON). Hemodynamic parameters were continuously monitored. Regional contractile wall function was quantified with ultrasonic crystals aligned to measure wall thickening. At the end of the protocol, infarct size (IS, as percentage of risk region) was determined by incubating the myocardium with p-nitrobluetetrazolium. With comparable myocardium at risk, infusion of U-89232 before 60 min of LADCA occlusion significantly reduced infarct size (IS, 18.5 +/- 3.7%; p < 0.001 vs. 63.2 +/- 3.3% for the controls), whereas glibenclamide had no effect on infarct size (IS, 69.5 +/- 4.4%). The administration of glibenclamide before U-89232 infusion blocked the infarct size-reducing effect of U-89232 [IS, 61.2 +/- 9.1 (NS) vs. controls and p < 0.001 vs. U]. Infusion of U-89232 had no effect on hemodynamic parameters or on regional wall function. At least in a pig model, U-89232 appears to be a cardioselective KATP channel opener, because in the absence of hemodynamic alterations, it exhibits a profound cardioprotective effect, which is fully reversible by blocking KATP channels.

摘要

我们确定了ATP敏感性钾通道(KATP)开放剂色满卡林的衍生物U-89232是否具有心脏选择性,以及其对心肌的作用是否仍对格列本脲敏感。实验在开胸猪身上进行,这些猪经历了60分钟的左冠状动脉前降支闭塞(LADCA)并再灌注2小时。研究了四组动物(每组n = 6)。在LADCA闭塞前,动物分别接受U-89232(3mg/kg静脉注射,持续15分钟,U组)或选择性KATP通道阻滞剂格列本脲(1mg/kg静脉注射,持续15分钟,GLI组)。在GLI + U组中,在缺血60分钟前先输注格列本脲(1mg/kg/15分钟),然后输注U-89232(3mg/kg/15分钟)。生理盐水处理的动物作为对照(CON组)。连续监测血流动力学参数。用排列好的超声晶体测量室壁增厚来量化局部收缩性室壁功能。在实验结束时,通过用对硝基蓝四氮唑孵育心肌来确定梗死面积(IS,占危险区域的百分比)。在有相当危险心肌的情况下,在LADCA闭塞60分钟前输注U-89232可显著减小梗死面积(IS,18.5±3.7%;与对照组的63.2±3.3%相比,p < 0.001),而格列本脲对梗死面积无影响(IS,69.5±4.4%)。在输注U-89232前给予格列本脲可阻断U-89232减小梗死面积的作用[IS,61.2±9.1(无显著性差异)与对照组相比,与U组相比p < 0.001]。输注U-89232对血流动力学参数或局部室壁功能无影响。至少在猪模型中,U-89232似乎是一种心脏选择性KATP通道开放剂,因为在无血流动力学改变的情况下,它表现出显著的心脏保护作用,通过阻断KATP通道可使其完全逆转。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验